The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.






Clinical Director, Division of Medicine and Cancer
Westmead Hospital

Honoured “for eminent service to medicine, particularly in the areas of clinical and biomedical research, to the development of ethical policy and practices for organ donation, acquisition and transplantation, and to renal medicine organisations and publications, Jeremy Chapman AC has played significant roles in development of kidney, pancreas and unrelated Bone Marrow Transplantation in Australia. He has been responsible for global development of ethical transplantation through The Transplantation Society, the World Marrow Donor Association and through advisory roles to the World Health Organisation. He is identified as one of the most influential global leaders in the field of clinical transplantation.

Professor of Pharmacology and NHMRC Senior Principal Research Fellow
Monash Institute of Pharmaceutical Sciences

“Discovery and dissemination of the concept of allosteric sites on receptor proteins as a novel avenue for drug discovery”.
Professor Christopoulos has demonstrated how this approach can be used to identify, validate, quantify, and facilitate preclinical translation of small molecules with an allosteric mode of action for all classes of G protein-coupled receptor (GPCR), the largest group of drug targets. His research is highly cited (top 1% in discipline), has made it into the textbooks, been acknowledged via the highest honours from the Australian, USA, UK and world (IUPHAR) Pharmacological Societies, and transformed the way GPCR drug modulators are discovered.

Lorimer Dods Professor and Director
Children’s Medical Research Institute

Professor Roger Reddel is a medical oncologist and cancer researcher who is internationally recognised for major contributions to understanding cellular immortality – an almost universal characteristic of cancers – and especially the role of telomere lengthening mechanisms. He also has a medical research leadership role as executive director of Children’s Medical Research Institute, and within many medical research networks including Sydney Health Partners. He is Director of CellBank Australia, and co-director of the Australian Cancer Research Foundation International Centre for the Proteome of Human Cancer, which aims to improve the accuracy of treatment decisions for individual cancer patients.




Co-Medical Director and Chair of Melanoma Medical Oncology and Translational Research
Melanoma Institute Australia, The University of Sydney

GL BSc(UM) PhD MBBS FRACP, Co-Medical Director of Melanoma Institute Australia, and President-elect for the prestigious international ‘Society for Melanoma Research’, is an international key-opinion leader in melanoma medical oncology and translational research, focusing on drivers of response and resistance to novel drugs. GL has published >130 peer-reviewed papers since 2011 (6xNEngJMed), and has obtained major NHMRC program-grant funding (co-chief investigator). GL has been an invited speaker at >120 international meetings, is Scientific Committee Track-Leader for the prestigious American Society for Clinical Oncology 2015/16, and for the European equivalent (ESMO ’18/ESMO-Asia ’17). She is a member of key boards, steering committees (AJCC staging), and guideline working-groups, is associate-editor and reviewer for high-impact journals (+editorial boards), & reviews grants (NHMRC).








Head, Brain and Behaviour Research Focus Area
Telethon Kids Institute

Stephen Zubrick is a leading developmental scientist. He pioneered the first Australian population studies of the prevalence and burden of mental disorders in Australian children and adolescents. He and his team went on to conduct the landmark Western Australian Aboriginal Child Health Survey. Along with his team he has led the 1998 and 2014 National Surveys of Child and Adolescent Mental Health. He is a creator and leader of the National Longitudinal Study of Australian Children. His work has guided policies and services for children across Australia and placed Australian child and adolescent mental health into a global perspective.



Head, Epidemiology for Policy and Practice Group
Australian National University

Professor Emily Banks is an award-winning epidemiologist and public health physician. Her research uses large-scale population data to identify potentially modifiable factors affecting individual and population health in different settings, to inform improvements in health and health care. She is recognised nationally and internationally for her work on cancer, cardiovascular disease, medication safety and Aboriginal health, including research on breast cancer and hormone replacement therapy and the health effects of smoking. She is Head of Epidemiology for Policy and Practice Group at the National Centre for Epidemiology and Population Health and Scientific Director of the 45 and Up Study.

Head, Ageing and Physical Disability Program Musculoskeletal Health Sydney, School of Public Health
The University of Sydney

Prof Sherrington is an NHMRC Senior Research Fellow at the George Institute for Global Health and Sydney Medical School, The University of Sydney. She leads the 17-person Ageing and Physical Disability Research Group within the Institute’s Musculoskeletal Division. Her research focuses on the promotion of physical activity and prevention of falls in older people and people with chronic disabling conditions. Her publications have been cited over 12,600 times. She is an international pioneer in the conduct of large-scale pragmatic clinical trials and systematic reviews about exercise and falls prevention. She has been Chief Investigator on NHMRC grants totalling $15.2 million.

Director, Genetics Theme and Group Co-Leader, Brain and Mitochondrial Research Group; Chair in Genomic Medicine, Department of Paediatrics, The University of Melbourne
Murdoch Childrens Research Institute

John Christodoulou is clinical geneticist working in the management of children with inborn errors of metabolism for over 25 years.  He has a longstanding interest in Rett syndrome (RTT), with a potential new therapy and the discovery the second gene associated with RTT as notable achievements.  More recently, using next generation sequencing (NGS) he identified a number of new disease genes which directly led to specific therapies.  As an executive team member of the Australian Genomics Health Alliance, he will oversee the generation of evidence to convince policymakers that NGS should be equitably introduced nationally into mainstream medical practice.

Professor and Chair of Regenerative Medicine
Institute of Health and Biomedical Innovation, Queensland University of Technology

Over the last decade Professor Hutmacher has gained a worldwide reputation in the field of tissue engineering& regenerative medicine (TE&RM), and his track record illustrates successful mastery of a major challenge in biomedical sciences: the ability to transcend traditional disciplinary boundaries, and initiate and nurture research and educational programs across different disciplines. This success has been achieved through a concerted and integrated leadership effort including contributions from colleagues in engineering (tissue engineering, biomaterials science, computational modelling, chemistry, nanotechnology), the life science disciplines (molecular cell and developmental biology, medicine, stem cell research, genomics, proteomics, bioinformatics), and applied clinical research (orthopaedics, craniofacial &plastic surgery, oncology, radiology).

Director, ACRF-Centenary Cancer Research Centre
The Centenary Institute

Phil Hogg discovered a unique mechanism of control of protein function that operates across all biological systems and lifeforms. This involves a subset of disulphide bonds thought only to act as covalent modifiers of protein structure functioning as molecular switches to allosterically regulate protein function when cleaved. He developed a novel classification scheme for disulphides and uncovered a conformational signature for the allosteric bonds that underpins their facile nature. He has shown that thrombosis as well as immune responses and viral infections are critically regulated by this previously unrecognised chemical modification.



Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.